Back to top
more

Ecolab (ECL)

(Delayed Data from NYSE)

$244.57 USD

244.57
1,399,786

-1.16 (-0.47%)

Updated Nov 1, 2024 04:00 PM ET

After-Market: $244.55 -0.02 (-0.01%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value B Growth B Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 43% (142 out of 250)

Industry: Chemical - Specialty

Better trading starts here.

Zacks News

Ecolab (ECL) Launches Roach Control Device for Food Outlets

Ecolab's (ECL) latest device is expected to help the restaurant industry efficiently protect their brand reputation and eliminate any business and public health risk.

MTX or ECL: Which Is the Better Value Stock Right Now?

MTX vs. ECL: Which Stock Is the Better Value Option?

AXTA vs. ECL: Which Stock Should Value Investors Buy Now?

AXTA vs. ECL: Which Stock Is the Better Value Option?

Ecolab (ECL) Misses Q1 Earnings Estimates

Ecolab (ECL) delivered earnings and revenue surprises of -1.22% and 0.86%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

Ecolab (ECL) Q1 Earnings Miss, Revenues Surpass Estimates

Although Ecolab's (ECL) first-quarter results reflect weakness in the Global Industrial and Institutional segments, its Global Healthcare and Life Sciences unit shows strength.

Ecolab (ECL) to Report Q1 Earnings: What's in the Offing?

Ecolab's (ECL) first-quarter results are likely to reflect strength in the Global Healthcare and Life Sciences segment.

Sweta Killa headshot

Materials Sector to Rejoice in Q1 Earnings: ETFs to Play

The solid trend for materials ETFs is likely to continue as Q1 earnings unfold.

ICL vs. ECL: Which Stock Is the Better Value Option?

ICL vs. ECL: Which Stock Is the Better Value Option?

Anindya Barman headshot

4 Chemical Specialty Stocks to Buy From a Rebounding Industry

The Zacks Chemicals Specialty industry is poised to run higher on a rebound in global industrial and manufacturing activities. Celanese (CE), Ashland (ASH), Daqo New Energy (DQ) and Element Solutions (ESI) are set to gain from demand recovery and self-help actions.

Here's Why You Should Hold on to Ecolab (ECL) Stock for Now

Ecolab (ECL) continues to gain traction for a solid product portfolio and cost-efficiency program. However, segmental weakness is worrisome.

ICL vs. ECL: Which Stock Should Value Investors Buy Now?

ICL vs. ECL: Which Stock Is the Better Value Option?

Ecolab (ECL) Unveils Its Enhanced Smart Water Navigator

Ecolab's (ECL) smart tool is expected to bridge the widening gap between freshwater supply and demand via efficient water management.

Why Is Ecolab (ECL) Up 0.2% Since Last Earnings Report?

Ecolab (ECL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Ecolab's (ECL) Certified Program to Build Customer Confidence

Ecolab's (ECL) science-backed comprehensive program to help food retailers to support customer confidence.

Ecolab (ECL) Q4 Earnings In Line With Estimates, Revenues Lag

Although Ecolab's (ECL) fourth-quarter results reflect weakness in the Global Industrial and Institutional segments, its Global Healthcare and Life Sciences unit shows strength.

Ecolab (ECL) to Report Q4 Earnings: What's in the Offing?

Ecolab's (ECL) fourth-quarter results are likely to reflect gains from the Global Healthcare and Life Sciences segment.

Earnings Preview: Ecolab (ECL) Q4 Earnings Expected to Decline

Ecolab (ECL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Quidel (QDEL) to Report Q4 Earnings: What's in the Offing?

Quidel (QDEL) is likely to have witnessed a recovery in rapid immunoassay revenues during Q4.

DuPont (DD) Warms Up to Q4 Earnings: What's in the Offing?

DuPont (DD) is likely to have benefited from its cost and productivity actions in the fourth quarter.

Cardinal Health (CAH) to Post Q2 Earnings: What's in Store?

Cardinal Health's (CAH) fiscal second-quarter results are likely to reflect solid performance in Pharmaceutical segment.

What's in Store for Meridian Bioscience's (VIVO) Q1 Earnings?

Meridian Bioscience's (VIVO) fiscal first-quarter results are likely to reflect strong performance by Life Science business line.

Air Products (APD) to Post Q1 Earnings: What's in the Cards?

Benefits of productivity and pricing actions, new plants and acquisitions are expected to get reflected on Air Products' (APD) Q1 results.

CE vs. ECL: Which Stock Should Value Investors Buy Now?

CE vs. ECL: Which Stock Is the Better Value Option?

AmerisourceBergen (ABC) to Post Q1 Earnings: What's in Store?

AmerisourceBergen's (ABC) fiscal first-quarter results are likely to reflect solid performance at Pharmaceutical Distribution and Other units.

Baxter (BAX) to Report Q4 Earnings: What's in the Cards?

Baxter's (BAX) fourth-quarter performance is likely to reflect growth in its Acute Therapies business.